DR5 and DcR2 are expressed in human lumbar intervertebral discs

Spine

Volumn 34, Issue 19, 2009, Pages

  Chen, Bohua ^a   Ma, Bin ^a   Yang, Shangyou ^b   Xing, Xiuhua ^c   Gu, Run ^a   Hu, Yougu ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b WICHITA STATE UNIVERSITY   (United States)

^c Municipal Hospital   (China)

Author keywords

DcR2; DR5; Intervertebral disc; Lumbar vertebrae; Receptors; TNFRelated Apoptosis Inducing Ligand (TRAIL)

Indexed keywords

CYTOKINE RECEPTOR; DEATH RECEPTOR 5; DECOY RECEPTOR 2; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUMBAR DISK; LUMBAR DISK HERNIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; APOPTOSIS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK DISPLACEMENT; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR DECOY RECEPTORS; YOUNG ADULT;

EID: 70349116101     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181b4d4ee     Document Type: Article

References (17)

1. Waddell G. Low back pain: a twentieth century health care enigma. Spine 1996;21:2820-2825
2. Gruber HE, Hanley EN. Analysis of aging and degeneration of the human intervertebral disc. Comparison of surgical specimens with normal controls. Spine 1998;23:751-757
3. Park JB, Kim KW, Han CW, et al. Expression of Fas receptor on disc cells in herniated lumbar disc tissue. Spine 2001;26:142-146
4. Park JB, Chang H, Kim KW. Expression of Fas ligand and apoptosis of disc cells in herniated lumbar disc tissue. Spine 2001;26:618-621
5. Chen B, Fellenberg J, Wang H, et al. Occurrence and regional distribution of apoptosis in scoliotic discs. Spine 2005;30:519-524
6. Bachmeier BE, Nerlich AG, Weiler C, et al. Analysis of tissue distribution of TNF-alpha, TNF-alpha-receptors, and the activating TNF-alpha-converting enzyme suggests activation of the TNF-alpha system in the aging intervertebral disc. Ann N Y Acad Sci 2007;1096:44-54.
7. Weiler C, Nerlich AG, Bachmeier BE, et al. Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls. Spine 2005;30:44-53; discussion 54.
8. Nagata S. Apoptosis by death factor. Cell 1997;88:355-365
9. Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995;3: 673-682
10. Tao Niu, Bohua Chen, Yougu Hu. Expression and distribution of TRAIL in normal human intervertebral discs. Acta Academiae Medicinae Qingdao Universitatis [J] 2007;43:265-266
11. Bodmer JL, Holler N, Reynard S, et al. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol 2000;2:241-243
12. Thorburn A. Death receptor-induced cell killing. Cell Signal 2004;16:139-44.
13. Mérino D, Lalaoui N, Morizot A, et al. Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2. Mol Cell Biol 2006;26:7046-7055
14. Bibby SR, Urban JP. Effect of nutrient deprivation on the viability of intervertebral disc cells. Eur Spine J 2004;13:695-701.
15. Bouralexis S, Findlay DM, Atkins GJ, et al. Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy. Br J Cancer 2003;89:206-214
16. Clancy L, Mruk K, Archer K, et al. Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis. Proc Natl Acad Sci USA 2005;102: 18099-18104
17. Riccioni R, Pasquini L, Mariani G, et al. TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL. Haematologica 2005; 90:612-624